Showing 3181-3190 of 4166 results for "".
- Bausch + Lomb Ultra Multifocal for Astigmatism Contact Lenses Now Available In the United Stateshttps://modernod.com/news/bausch-lomb-ultra-multifocal-for-astigmatism-contact-lenses-now-available-in-the-united-states/2476671/Bausch + Lomb announced the US launch of Bausch + Lomb Ultra Multifocal for Astigmatism contact lenses. The new monthly silicone hydrogel lens, which was specifically designed to address the lifestyle and vision n
- Key to Workplace Productivity May Be in the Eyeshttps://modernod.com/news/key-to-workplace-productivity-may-be-in-the-eyes/2476606/While employers are constantly striving to enhance worker productivity, a new study from the journal Ophthalmology suggests a solution: correcting nearsightedness. Conducted by global researchers, the study indicates that vision impairment caused by uncorrected myopia cost the globa
- Wills Eye Hospital Research Suggests Glaucoma Patients May Be at Higher Risk of Motor Vehicle Accidents Than Those of Similar Agehttps://modernod.com/news/wills-eye-hospital-research-suggests-glaucoma-patients-may-be-at-higher-risk-of-motor-vehicle-accidents-than-those-of-similar-age/2476601/In a study recently presented at The Association for Research in Vision and Ophthalmology (ARVO), researchers from Wills Eye Hospital in Philadelphia studied the rate of car accidents in patients with glaucoma. They found that the rate of those accidents among pat
- Nicox Presents First Data on New Class of Nitric Oxide (NO)-Donating Compounds for Glaucoma at ARVOhttps://modernod.com/news/nicox-presents-first-data-on-new-class-of-nitric-oxide-no-donating-compounds-for-glaucoma-at-arvo/2476545/Nicox SA announced that it has presented the first data from a new drug class designed to lower IOP (NO-donating PDE5 inhibitors) at a poster presentation during the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO). The first
- MeiraGTx Announces Upcoming Presentation on Achromatopsia Gene Therapy Candidate AAV-CNGA3 at ARVO 2019https://modernod.com/news/meiragtx-announces-upcoming-presentation-on-achromatopsia-gene-therapy-candidate-aav-cnga3-at-arvo-2019/2476504/MeiraGTx Holdings announced a preclinical poster on safety and efficacy of the company’s gene therapy product candidate AAV-CNGA3 for the treatment of patients with achromatopsia (ACHM) due to mutations in the CNGA3 gene will be presented at the Association for Research in Vision and Oph
- User-Friendly Visual-Acuity Chart Shows Good Agreement With Existing Chartshttps://modernod.com/news/user-friendly-visual-acuity-chart-shows-good-agreement-with-existing-charts/2476405/The Runge near-vision card is user-friendly and shows good agreement with the Early Treatment Diabetic Retinopathy Study (ETDRS) and Snellen visual-acuity charts, researchers report, according to Reuters Health. “The Runge nea
- Former Lens Butler Executives Have Launched Boxsee Contact Lens Subscription Servicehttps://modernod.com/news/former-lens-butler-executives-have-launched-boxsee-contact-lens-subscription-service/2476382/Two former executives of The Lens Butler, Beth Samenuk and Allison Granger, have established a new company and brand, Boxsee, which they say “represents a new vision for the future of their partnered contact lens subscription service,” according to a
- Glycemic Control Tied to Better Outcome of Anti-VEGF Therapy for Diabetic Macular Edemahttps://modernod.com/news/glycemic-control-tied-to-better-outcome-of-anti-vegf-therapy-for-diabetic-macular-edema/2476309/Strong glycemic control may optimize vision outcomes in patients with diabetic macular edema (DME) treated with anti-vascular endothelial growth factor (anti-VEGF) therapy, researchers say, according to a Reuters report. Dr. Jennif
- Founders of The Lens Butler Announce Boxsee, a New Contact Lens Subscription Servicehttps://modernod.com/news/founders-of-the-lens-butler-announce-boxsee-a-new-contact-lens-subscription-service/2476342/Beth Samenuk and Allison Granger, formerly of The Lens Butler, announced their new company and brand, Boxsee. The company represents a new vision for the future of their partnered contact lens subscription service and increases their o
- Ocutech Starts Roll-Out of New VES Falcon Autofocus Bioptic Telescopehttps://modernod.com/news/ocutech-starts-national-roll-out-of-new-ves-falcon-autofocus-bioptic-telescope/2479599/Ocutech announced the release of the new VES Falcon Autofocus Bioptic Telescope to low vision specialists internationally. The Falcon is the next generation of the world’s only autofocusing bioptic telescope for the visually impaired, according to Ocutech. The Falcon’s advanced technology